Glizid-M XR 30 Tablet

Description

Glizid-M XR 30 Tablet is a combination oral antidiabetic medicine containing Gliclazide 30 mg and Metformin 500 mg in an extended-release (XR) formulation. It helps manage Type 2 Diabetes Mellitus by gradually releasing the active ingredients, providing stable blood glucose control throughout the day. Gliclazide stimulates insulin release, while Metformin improves insulin sensitivity and reduces glucose production in the liver.

Uses

• Management of Type 2 Diabetes Mellitus when diet, exercise, or a single medicine is insufficient

Dosage

• Take as prescribed by your doctor

• Usually taken once daily, depending on blood sugar levels and individual response

• Dose adjustments may be needed based on blood sugar monitoring

How to Use

• Take orally with water

• Preferably with breakfast to reduce gastrointestinal side effects

• Swallow the tablet whole; do not crush or chew

• Follow dietary and exercise recommendations provided by your doctor

Precautions

• Not for Type 1 diabetes or diabetic ketoacidosis

• Inform your doctor if you have kidney or liver problems

• Monitor blood sugar regularly

• Avoid excessive alcohol consumption

• Use with caution during pregnancy or breastfeeding

Side Effects

Common side effects may include:

• Hypoglycemia (low blood sugar, mainly due to Gliclazide)

• Nausea, vomiting, diarrhea, or stomach discomfort (mainly due to Metformin)

• Headache

• Bloating or mild abdominal discomfort

• Weight gain

Seek immediate medical advice if severe hypoglycemia occurs or if unusual symptoms appear.